Index RUT
P/E -
EPS (ttm) -0.91
Insider Own 13.69%
Shs Outstand 63.25M
Perf Week -7.52%
Market Cap 799.75M
Forward P/E -
EPS next Y -0.03
Insider Trans -0.10%
Shs Float 54.65M
Perf Month -24.69%
Income -55.46M
PEG -
EPS next Q 0.02
Inst Own 79.72%
Short Float 9.68%
Perf Quarter -16.10%
Sales 248.33M
P/S 3.22
EPS this Y 63.89%
Inst Trans -2.29%
Short Ratio 8.24
Perf Half Y 8.30%
Book/sh 0.09
P/B 135.95
EPS next Y 87.99%
ROA -27.90%
Short Interest 5.29M
Perf Year 27.36%
Cash/sh 1.35
P/C 9.41
EPS next 5Y 16.50%
ROE -861.68%
52W Range 9.38 - 17.82
Perf YTD 20.23%
Dividend Est. -
P/FCF -
EPS past 5Y 10.81%
ROI -41.34%
52W High -28.96%
Beta 1.29
Dividend TTM -
Quick Ratio 2.23
Sales past 5Y 44.65%
Gross Margin 67.81%
52W Low 34.97%
ATR (14) 0.64
Dividend Ex-Date -
Current Ratio 2.47
EPS Y/Y TTM 17.75%
Oper. Margin -12.71%
RSI (14) 38.82
Volatility 3.50% 5.21%
Employees 273
Debt/Eq 22.05
Sales Y/Y TTM 34.43%
Profit Margin -22.33%
Recom 1.14
Target Price 23.43
Option/Short Yes / Yes
LT Debt/Eq 21.78
EPS Q/Q -2.29%
Payout -
Rel Volume 0.36
Prev Close 12.69
Sales Surprise -3.31%
EPS Surprise -31.14%
Sales Q/Q 22.12%
Earnings Nov 06 AMC
Avg Volume 641.91K
Price 12.66
SMA20 -1.11%
SMA50 -15.66%
SMA200 -7.66%
Trades
Volume 233,511
Change -0.24%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-29-24 Upgrade
Barclays
Equal Weight → Overweight
$10 → $16
Jun-23-22 Initiated
Needham
Buy
$18
May-12-22 Upgrade
Barclays
Underweight → Equal Weight
$8 → $10
Jan-20-22 Upgrade
Truist
Hold → Buy
$11
May-06-21 Upgrade
Mizuho
Neutral → Buy
$15
Apr-08-21 Reiterated
H.C. Wainwright
Buy
$20 → $22
Feb-24-21 Downgrade
Truist
Buy → Hold
$12
Jul-07-20 Downgrade
Mizuho
Buy → Neutral
$8 → $3
Feb-06-20 Resumed
Mizuho
Buy
Nov-26-19 Initiated
SVB Leerink
Outperform
$25
Sep-05-19 Resumed
Mizuho
Buy
$30
Jun-28-19 Initiated
Wells Fargo
Market Perform
$16
Jun-11-19 Initiated
Barclays
Underweight
$13
Mar-20-19 Initiated
SunTrust
Buy
$30
Feb-14-19 Initiated
H.C. Wainwright
Buy
$37
Jan-29-19 Initiated
Stifel
Buy
$27
Show Previous Ratings
Nov-18-24 09:55AM
Nov-14-24 09:35AM
Nov-07-24 06:00AM
Nov-06-24 06:25PM
04:05PM
08:00AM
Loading…
Nov-01-24 08:00AM
Oct-31-24 02:02PM
Oct-30-24 10:01AM
Oct-29-24 08:00AM
Oct-23-24 08:00AM
Oct-11-24 10:53PM
Oct-09-24 03:36PM
Sep-27-24 09:00PM
Sep-06-24 08:00AM
Aug-09-24 04:30PM
07:39AM
Loading…
07:39AM
Aug-01-24 04:00PM
(Investor's Business Daily) +13.04%
Jul-31-24 09:56PM
06:45PM
04:05PM
08:00AM
Jul-30-24 08:00AM
Jul-25-24 08:00AM
Jul-23-24 07:03AM
(Pharmaceutical Technology)
Jul-17-24 08:00AM
Jul-01-24 08:00AM
Jun-24-24 08:00AM
Jun-12-24 08:00AM
Jun-07-24 05:00PM
May-28-24 01:00AM
10:57AM
Loading…
May-21-24 10:57AM
May-20-24 08:30AM
May-16-24 02:54AM
02:54AM
May-15-24 08:30AM
May-10-24 06:55PM
09:10AM
May-08-24 11:09AM
07:24AM
(Thomson Reuters StreetEvents)
03:53AM
May-07-24 08:58PM
06:35PM
05:46PM
04:05PM
May-02-24 07:37AM
Apr-23-24 04:30PM
Apr-21-24 10:39AM
Apr-17-24 04:05PM
Apr-12-24 04:05PM
Mar-26-24 08:00AM
Mar-14-24 07:04AM
Mar-13-24 09:55AM
Mar-11-24 07:00AM
Mar-08-24 04:05PM
03:24PM
12:30PM
(Thomson Reuters StreetEvents)
Mar-07-24 10:34PM
09:53PM
04:05PM
Mar-04-24 08:28PM
Mar-01-24 08:30AM
Feb-27-24 08:30AM
Feb-22-24 04:30PM
Feb-09-24 04:05PM
Feb-02-24 09:10PM
Jan-16-24 05:28PM
Jan-12-24 04:23PM
Jan-09-24 06:21PM
Jan-04-24 04:05PM
Dec-20-23 08:00AM
Dec-08-23 04:30PM
Nov-13-23 09:08AM
Nov-10-23 05:16PM
Nov-07-23 04:16PM
Nov-06-23 08:45AM
Nov-01-23 08:45AM
Oct-25-23 08:45AM
08:45AM
Oct-08-23 06:41PM
Sep-29-23 04:05PM
Sep-13-23 04:10PM
Sep-09-23 01:03PM
Sep-03-23 05:29AM
Aug-29-23 08:45AM
Aug-27-23 07:20PM
Aug-23-23 06:53PM
Aug-21-23 08:45AM
Aug-08-23 09:15AM
08:45AM
Aug-02-23 05:45PM
04:05PM
Jul-27-23 11:42AM
08:45AM
Jul-26-23 10:02AM
08:45AM
Jul-19-23 08:45AM
Jul-15-23 07:30AM
Jun-29-23 09:00AM
Jun-22-23 08:45AM
Jun-08-23 04:05PM
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Beaver Sandra Chief Financial Officer Sep 06 '24 Sale 14.98 3,276 49,074 148,502 Sep 06 09:45 PM Yamagishi-Dressler Tomoko Chief Marketing Officer Aug 30 '24 Sale 15.85 5,631 89,251 82,375 Sep 04 04:14 PM MOATAZEDI DAVID See Remarks Jun 06 '24 Option Exercise 7.28 175,940 1,280,843 709,289 Jun 06 07:01 PM MOATAZEDI DAVID See Remarks Jun 05 '24 Option Exercise 5.46 155,278 847,818 688,627 Jun 06 07:01 PM MOATAZEDI DAVID See Remarks Jun 06 '24 Sale 12.59 175,940 2,214,486 533,349 Jun 06 07:01 PM MOATAZEDI DAVID See Remarks Jun 05 '24 Sale 12.92 155,278 2,006,456 533,349 Jun 06 07:01 PM MOATAZEDI DAVID See Remarks Jun 04 '24 Sale 12.73 140,214 1,784,686 533,349 Jun 06 07:01 PM Malik Vikram Director Jun 03 '24 Sale 12.96 7,500 97,203 246,514 Jun 05 09:30 PM GILL DAVID N Director May 14 '24 Sale 12.60 6,718 84,654 33,964 May 15 05:20 PM GILL DAVID N Director May 13 '24 Sale 12.72 3,643 46,356 40,682 May 15 05:20 PM Malik Vikram Director May 13 '24 Sale 12.93 28,000 362,012 254,014 May 15 05:19 PM MOATAZEDI DAVID See Remarks May 10 '24 Sale 12.72 16,051 204,127 673,563 May 14 08:56 PM Avelar Rui See Remarks May 10 '24 Sale 12.72 3,441 43,761 368,847 May 14 08:56 PM Beaver Sandra Chief Financial Officer May 10 '24 Sale 12.72 2,423 30,814 151,778 May 14 08:55 PM MOATAZEDI DAVID See Remarks Mar 27 '24 Sale 13.86 6,236 86,431 689,614 Mar 29 07:08 PM Avelar Rui See Remarks Mar 19 '24 Sale 13.92 27,603 384,350 372,288 Mar 21 06:09 PM Beaver Sandra Chief Financial Officer Mar 19 '24 Sale 13.92 5,672 78,978 154,201 Mar 21 06:09 PM MOATAZEDI DAVID See Remarks Mar 19 '24 Sale 13.92 96,566 1,344,604 695,850 Mar 21 06:08 PM MOATAZEDI DAVID See Remarks Feb 22 '24 Sale 13.08 7,706 100,804 792,416 Feb 23 08:27 PM Avelar Rui See Remarks Feb 22 '24 Sale 13.08 1,821 23,821 399,891 Feb 23 08:27 PM Beaver Sandra Chief Financial Officer Feb 22 '24 Sale 13.08 1,821 23,821 159,873 Feb 23 08:27 PM Parschauer Karah Herdman Director Jan 30 '24 Sale 13.14 11,931 156,733 31,243 Feb 02 04:57 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite